Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer

Steven B. Zeliadt, Arnold L. Potosky, David F. Penson, Ruth Etzioni

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences